Management of Sexually Transmitted Diseases in HIV-Infected Men and Women
Summary
- The quadrivalent human papillomavirus vaccine confers protection against HPV types 6/11 (responsible for 90% of genital warts) and 16/18 (responsible for 70% of cervical cancers)[Markowitz 2007]
- The quadrivalent vaccine is also approved by the FDA for prevention of anal cancer and associated precancerous lesions in persons infected with these HPV types[FDA 2010]
- The 9-valent human papillomavirus vaccine confers protection against HPV subtypes 6, 11, 16, 18, 31, 33, 45, 52, and 58
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content
Keywords: HPV, Sexually Transmitted Diseases, Women